# Fast parametric two-qubit gate for highly detuned fixed-frequency superconducting qubits using a double-transmon coupler

Article · Kentaro Kubo, Hayato Goto

- Archive id: arxiv:2212.06979
- Published: 2022-12-14
- Venue: Appl. Phys. Lett. 122, 064001 (2023)
- DOI: https://doi.org/10.1063/5.0138699
- arXiv: https://arxiv.org/abs/2212.06979
- Citations: 16
- Source URL: https://arxiv.org/abs/2212.06979
- PDF: https://arxiv.org/pdf/2212.06979
- Provenance: arxiv

## Abstract

High-performance two-qubit gates have been reported with superconducting qubits coupled via a single-transmon coupler (STC). Most of them are implemented for qubits with a small detuning since reducing residual $ZZ$ coupling for highly detuned qubits by an STC is challenging. In terms of the frequency crowding and crosstalk, however, highly detuned qubits are desirable. Here, we numerically demonstrate a high-performance parametric gate for highly detuned fixed-frequency qubits using a recently proposed tunable coupler called a double-transmon coupler (DTC). Applying an ac flux pulse, we can perform a maximally entangling universal gate ($\\sqrt{\\rm iSWAP}$) with an average fidelity over 99.99$\\%$ and a short gate time of about 24 ns. This speed is comparable to resonance-based gates for slightly detuned tunable qubits. Moreover, using a dc flux pulse alternatively, we can achieve another kind of entangling gate called a CZ gate with an average fidelity over 99.99$\\%$ and a gate time of about 18 ns. Given the frexibility and feasible settings, we can expect that the DTC will contribute to realizing a high-performance quantum computer in the near future.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [Superconducting Quantum Processors](https://space-kitty.com/topics/superconducting-qubits)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.